VCAM-1: Function, Significance & Clinical Relevance
VCAM-1 is a cell adhesion molecule expressed on vascular endothelial cells that plays a key role in inflammatory responses and is associated with atherosclerosis and autoimmune diseases.
Things worth knowing about "VCAM 1"
VCAM-1 is a cell adhesion molecule expressed on vascular endothelial cells that plays a key role in inflammatory responses and is associated with atherosclerosis and autoimmune diseases.
What is VCAM-1?
VCAM-1 (Vascular Cell Adhesion Molecule-1, also known as CD106) is a glycoprotein belonging to the immunoglobulin superfamily. It is primarily expressed on the surface of endothelial cells – the cells lining the inner wall of blood vessels. VCAM-1 acts as a docking site for specific immune cells, enabling their migration from the bloodstream into inflamed tissue.
Biological Function
VCAM-1 binds to the integrin VLA-4 (α4β1), which is found on the surface of leukocytes (white blood cells), particularly monocytes and lymphocytes. This binding is a critical step in the inflammatory process:
- Activated endothelial cells upregulate VCAM-1 expression in response to inflammatory signals such as TNF-α, IL-1β, and NF-κB activation.
- Leukocytes adhere to the vessel wall via VCAM-1 (adhesion).
- Immune cells then migrate through the vessel wall into the inflamed tissue (transmigration or diapedesis).
These processes are essential for a normal immune response but can lead to tissue damage when excessively activated.
Clinical Significance
Atherosclerosis and Cardiovascular Disease
One of the most important clinical associations of VCAM-1 is with atherosclerosis (hardening and narrowing of the arteries). In early atherosclerotic lesions, VCAM-1 is strongly upregulated on vascular endothelium, facilitating monocyte infiltration into the vessel wall and contributing to plaque formation. Elevated levels of sVCAM-1 (soluble form) in the blood are considered a potential biomarker for increased cardiovascular risk.
Autoimmune Diseases
VCAM-1 expression is elevated in numerous autoimmune conditions, including:
- Rheumatoid arthritis: Elevated VCAM-1 levels in synovial fluid and blood.
- Multiple sclerosis: VCAM-1 is involved in the migration of immune cells across the blood-brain barrier.
- Systemic lupus erythematosus (SLE): Correlation with disease activity.
- Inflammatory bowel disease (Crohn's disease, ulcerative colitis): Increased expression in intestinal tissue.
Oncology
VCAM-1 also plays a role in tumor biology. It can promote the adhesion of tumor cells to the endothelium and is thereby involved in hematogenous metastasis. Additionally, it is being investigated in the bone marrow microenvironment of hematological malignancies such as multiple myeloma.
VCAM-1 as a Biomarker
The soluble form of VCAM-1 (sVCAM-1) can be measured in blood serum and is used in clinical research as a marker for:
- Endothelial dysfunction
- Systemic inflammatory activity
- Disease activity in autoimmune conditions
- Cardiovascular risk stratification
Although sVCAM-1 is not yet a standard parameter in routine clinical practice, it is being intensively investigated as a prognostic and diagnostic biomarker.
Therapeutic Relevance
Due to its central role in inflammatory processes, VCAM-1 is an attractive therapeutic target. Approaches to inhibit the VCAM-1/VLA-4 interaction are clinically applied or under investigation:
- Natalizumab: A monoclonal antibody against α4-integrin (VLA-4), approved for multiple sclerosis and Crohn's disease, which inhibits lymphocyte migration into the brain and intestine.
- Vedolizumab: An antibody targeting α4β7-integrin, specifically developed for inflammatory bowel diseases.
- Further approaches to targeted VCAM-1 inhibition are in preclinical and clinical development.
References
- Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251(4995):788-791.
- Cook-Mills JM, Marchese ME, Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxidants & Redox Signaling. 2011;15(6):1607-1638.
- World Health Organization (WHO). Cardiovascular diseases: global burden and risk factors. WHO Technical Report, 2023. Available at: https://www.who.int
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.